Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ScandiDos is a Swedish medical technology company that specializes in advanced quality assurance (QA) solutions for radiation therapy in cancer treatment. The company is best known for its Delta4 family of products, which provide 3D dosimetry and real-time verification of radiation doses to ensure they are delivered precisely as planned. Their technology supports complex treatment techniques such as IMRT, VMAT, and TomoTherapy, helping clinics improve patient safety and treatment outcomes. In 2022, ScandiDos was acquired by IBA (Ion Beam Applications), a global leader in proton therapy and radiation equipment. The company continues to operate as a specialized unit within IBA, focusing on the development of dosimetry systems that integrate seamlessly into clinical workflows. ScandiDos serves a global market, providing essential tools for medical physicists and radiation oncologists worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ScandiDos.